文献速递甲状腺疾病

新型特异性甲状腺激素转运体SLC17A4的功能表征

Functional Characterization of the Novel and Specific Thyroid Hormone Transporter SLC17A4.
PubMed 文献 · Thyroid · 2022-01-01

本研究在瞬时过表达SLC17A4的COS-1细胞中系统表征该新型甲状腺激素转运体的特性:SLC17A4使T3和T4摄取增加约4倍、rT3增加1.5倍,T4摄取不依赖Na+和Cl-、受低细胞外pH刺激,并促进T3、T4及3,3'-T2外排;多种经典甲状腺激素转运体抑制剂均未减弱其转运。

要点

  • SLC17A4使COS-1细胞T3和T4摄取较对照增加约4倍、rT3增加1.5倍。
  • SLC17A4介导的T4摄取不依赖Na+和Cl-,受低细胞外pH刺激。
  • 经典甲状腺激素转运体抑制剂均未减弱SLC17A4介导的转运。

核心结论

  • SLC17A4促进T3和T4转运,对rT3和3,3'-T2转运效率较低;其甲状腺激素调控中的生理作用有待进一步研究揭示。

研究设计与样本

  • 在瞬时过表达SLC17A4的COS-1细胞中开展一系列成熟的甲状腺激素转运研究,检测不同孵育缓冲液中的细胞摄取、外排及抑制剂效应,并检测N-连接糖基化抑制剂衣霉素和Asn残基定点突变对SLC17A4功能的影响。

主要发现

  • SLC17A4使T3和T4的细胞摄取较对照细胞增加约4倍,使反向rT3摄取增加1.5倍。
  • SLC17A4介导的T4摄取不依赖Na+和Cl-,受低细胞外pH刺激,并被多种碘甲状腺原氨酸及其代谢物降低,尤其是含至少三个碘原子的物质,与丙氨酸侧链是否修饰无关。
  • 所研究的经典甲状腺激素转运体抑制剂均未减弱SLC17A4介导的甲状腺激素转运。
  • SLC17A4还促进T3和T4外排,对3,3'-二碘甲状腺原氨酸(T2)外排作用较弱。
  • 免疫印迹显示SLC17A4存在N-连接糖基化;突变研究确定位于细胞外环1的Asn66、Asn75和Asn90为主要糖基化位点。

局限性

  • 原文结论指出需进一步研究揭示SLC17A4在甲状腺激素调控中的生理作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: A recent genome-wide association study identified the SLC17A4 locus associated with circulating free thyroxine (T4) concentrations. Human SLC17A4, being widely expressed in the gastrointestinal tract, was characterized as a novel triiodothyronine (T3) and T4 transporter. However, apart from the cellular uptake of T3 and T4, transporter characteristics are currently unknown. In this study, we delineated basic transporter characteristics of this novel thyroid hormone (TH) transporter. Methods: We performed a broad range of well-established TH transport studies in COS-1 cells transiently overexpressing SLC17A4. We studied cellular TH uptake in various incubation buffers, TH efflux, and the inhibitory effects of different TH metabolites and known inhibitors of other TH transporters on SLC17A4-mediated TH transport. Finally, we determined the effect of tunicamycin, a pharmacological inhibitor of N-linked glycosylation, and targeted mutations in Asn residues on SLC17A4 function. Results: SLC17A4 induced the cellular uptake of T3 and T4 by ∼4 times, and of reverse (r)T3 by 1.5 times over control cells. The uptake of T4 by SLC17A4 was Na+ and Cl- independent, stimulated by low extracellular pH, and reduced by various iodothyronines and metabolites thereof, particularly those that contain at least three iodine moieties irrespective of the presence of modification at the alanine side chain. None of the classical TH transporter inhibitors studied attenuated SLC17A4-mediated TH transport. SLC17A4 also facilitates the efflux of T3 and T4, and to a lesser extent of 3,3'-diiodothyronine (T2). Immunoblot studies on lysates of transfected cells cultured in absence or presence of tunicamycin indicated that SLC17A4 is subject to N-linked glycosylation. Complementary mutational studies identified Asn66, Asn75, and Asn90, which are located in extracellular loop 1, as primary targets. Conclusions: Our studies show that SLC17A4 facilitates the transport of T3 and T4, and less efficiently rT3 and 3,3'-T2. Further studies should reveal the physiological role of SLC17A4 in TH regulation.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Groeneweg S, van Geest FS, Chen Z, et al. Functional Characterization of the Novel and Specific Thyroid Hormone Transporter SLC17A4. Thyroid. 2022. PMID: 34937426. doi:10.1089/thy.2021.0257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。